Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition Post author: Post published: May 20, 2024 Post category:uncategorized Bimodal drug that successfully cures obesity, hyperglycemia, and dyslipidemia in mouse models. You Might Also Like New gene-editing method can correct many disease-causing mutations in mammalian cells October 23, 2025 Recognizing perinatal heart failure early reduces life-threatening risks June 25, 2026 Patient’s own cartilage cells from surgery offer hope for hip repair August 19, 2025
New gene-editing method can correct many disease-causing mutations in mammalian cells October 23, 2025